Safety profile of atorvastatin-treated patients with low LDL-cholesterol levels
- 1 March 2000
- journal article
- research article
- Published by Elsevier BV in Atherosclerosis
- Vol. 149 (1), 123-129
- https://doi.org/10.1016/s0021-9150(99)00294-4
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsNew England Journal of Medicine, 1998
- Prevention of coronary heart disease in clinical practice Recommendations of the Second Joint Task Force of European and other Societies on Coronary PreventionEuropean Heart Journal, 1998
- Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol LevelsJAMA, 1998
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsNew England Journal of Medicine, 1996
- Prevention of Coronary Heart Disease with Pravastatin in Men with HypercholesterolemiaNew England Journal of Medicine, 1995
- Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five-year follow-up of the seven countries studyPublished by American Medical Association (AMA) ,1995
- Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)JAMA, 1993
- Lipids and risk of coronary heart disease The Framingham StudyAnnals of Epidemiology, 1992
- The cholesterol facts. A summary of the evidence relating dietary fats, serum cholesterol, and coronary heart disease. A joint statement by the American Heart Association and the National Heart, Lung, and Blood Institute. The Task Force on Cholesterol Issues, American Heart Association.Circulation, 1990
- Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham StudyJAMA, 1986